3.10

5.49% -0.18

After Hours: 3.13 0.03 +0.97%

Nanobiotix Adr (NBTX)

Overview News Price History Discussions Forecast

Nanobiotix Adr stock is traded at $3.10, with a volume of 219.33K. It is down -5.49% in the last 24 hours and down -23.80% over the past month. Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Previous Close:

$3.28

Open:

$3.39

24h Volume:

219.33K

Relative Volume:

8.75

Market Cap:

$146.95M

Revenue:

$27,600

Net Income/Loss:

$-36.04M

P/E Ratio:

-1.7492

EPS:

-1.7722

Net Cash Flow:

$-1.66M

1W Performance:

-6.91%

1M Performance:

-23.80%

6M Performance:

-26.31%

1Y Performance:

-53.31%

1-Day Range:

$3.10

$3.39

1-Week Range:

$3.10

$3.69

52-Week Range:

$2.76

$8.962

Nanobiotix Adr Stock (NBTX) Company Profile

Name

Nanobiotix Adr

Sector

Healthcare (1176)

Industry

Biotechnology (673)

Phone

Address

Employee

110

Twitter

Next Earnings Date

2024-11-10

Latest SEC Filings

NBTX's Discussions on Twitter

Compare NBTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NBTX Nanobiotix Adr	3.10	146.95M	27,600	-36.04M	-1.66M	-0.7968
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146